The pharmaceutical industry is signaling resistance to a Trump administration plan to require that the list price be included for most drugs in television ads, setting the stage for a protracted fight over a proposal with broad bipartisan support.
from WSJ.com: US Business https://ift.tt/2Ep3vgQ
via IFTTT
No comments:
Post a Comment